Page 6 - Dr Reddy's Laboratories Limited

Dr Reddy's Laboratories, Zydus Pharma recall products in US market

Dr Reddy's Laboratories, Inc, the US arm of Dr Reddy's Laboratories, is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg

India's worst-performing stock in July may rebound if history is any guide

Shares of pharma firm Dr Reddy's Labs have rallied about 15% after losing steam

DRDO to get 2% royalty from Dr Reddy's on sale of Covid drug 2-DG in India

The drug comes in powder form in sachet and is taken orally by dissolving it in water.

Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months

Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results

Sputnik V soft launched in over 50 cities in India: Dr Reddy's Laboratories

Dr Reddys Laboratories Ltd, which soft-launched Russia's Covid-19 vaccine, Sputnik V here on May 14 has expanded the pilot project to over 50 other cities and towns in the country

Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's

Dr. Reddy's had received about 3 million first doses by June 1 and about 360,000 doses of the second by early this month, the company and the Indian government have said

Nifty outlook & trading ideas by HDFC Sec: Buy Bajaj Finance, Dr Reddy's

Bajaj Finance's stock price has broken out from symmetrical triangle on the daily charts, and rising volumes have confirmed the breakout

Dr Reddy's bullish on OTC products sale through Amazon, others in US

Dr Reddy's first began selling its OTC Habitrol brand nicotine patches on Amazon in 2016, as an experiment.

Sensex, Nifty post fourth straight weekly rise; Dr Reddy's rises over 3%

After rising 341 points, the Sensex settled 174 points, or 0.33 per cent, higher at 52,475

Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout

Rockwell Industries has got orders for 750 Covid19 vaccine freezers from hospitals and institutions.

Dr Reddy's lines up Rs 1,000 cr capex for current fiscal on growth outlook

Dr Reddy's Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal, top company official said

Shilpa Medicare jumps 26% in 2 days on tie-up with DRL for Covid vaccine

The company has entered into a three-year Definitive Agreement with Dr. Reddy's for production-supply of the Sputnik V vaccine

Russia's Sputnik V vaccine for Covid priced at Rs 948 plus 5% GST in India

Inoculation could be cheaper when it is manufactured domestically, says Hyderabad company.

Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine

Now, the Drugs Controller General of India DCGI will consider this recommendation and decide whether to grant Sputnik V approval for restricted emergency use in India

Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs

Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade

Dr Reddy's Labs terminates Kuwait-based Covid-19 treatment study

Dr Reddy's Laboratories on Wednesday announced termination of Avigan trial study being conducted in Kuwait

Sensex up 248 pts at 49,517; Nifty at 14,563; SBI, Airtel soar 4%, RIL 3%

Stock market updates: Nifty PSU Bank index surged over 6 per cent and was the top sectoral gainer

PM holds virtual meet with teams developing, manufacturing Covid-19 vaccine

The teams were from Gennova Biopharmaceuticals Ltd in Pune, Biological E Ltd and Dr Reddys Laboratories Ltd in Hyderabad.

Dr Reddy's gets nod for 2/3 vaccine trial; Key updates about the virus

A PMO release said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III

Strong support exists for Nifty at 10,900: CapitalVia Global Research

A short-covering move, along with addition of fresh position, is seen only if somehow Nifty sustains level of 11,200